EDGAR Filing Documents for 0001396814-17-000029

Form 8-K - Current report:

SEC Accession No. 0001396814-17-000029

Filing Date

2017-11-08

Accepted

2017-11-08 07:43:22

Documents

Period of Report

2017-11-08

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a8-kxpcrxq32017earningscall.htm	8-K	26204
2	EXHIBIT 99.1	pcrx-09302017x991.htm	EX-99.1	311666
3		paciralogo1a07.jpg	GRAPHIC	76073
	Complete submission text file	0001396814-17-000029.txt		444061

Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054

Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560

Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 171185110
SIC: 2834 Pharmaceutical Preparations